Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. (Q43147444)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 February 2010
edit
Language Label Description Also known as
English
Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer.
scientific article published on 26 February 2010

    Statements

    Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit